Kalfeist, L.;                     Galland, L.;                     Ledys, F.;                     Ghiringhelli, F.;                     Limagne, E.;                     Ladoire, S.    
        Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era. Cells 2022, 11, 770.
    https://doi.org/10.3390/cells11050770
    AMA Style
    
                                Kalfeist L,                                 Galland L,                                 Ledys F,                                 Ghiringhelli F,                                 Limagne E,                                 Ladoire S.        
                Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era. Cells. 2022; 11(5):770.
        https://doi.org/10.3390/cells11050770
    
    Chicago/Turabian Style
    
                                Kalfeist, Laura,                                 Loïck Galland,                                 Fanny Ledys,                                 François Ghiringhelli,                                 Emeric Limagne,                                 and Sylvain Ladoire.        
                2022. "Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era" Cells 11, no. 5: 770.
        https://doi.org/10.3390/cells11050770
    
    APA Style
    
                                Kalfeist, L.,                                 Galland, L.,                                 Ledys, F.,                                 Ghiringhelli, F.,                                 Limagne, E.,                                 & Ladoire, S.        
        
        (2022). Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era. Cells, 11(5), 770.
        https://doi.org/10.3390/cells11050770